Portugal is on the forefront of cancer research PDF Print E-mail
Thursday, 07 October 2010 04:19

The legacy of Antonio Champalimaud used to finance the 150 million it has cost the work

The highest authorities of Portugal and two Nobel prize-James Watson (1962) and Susumu Tonegawa (1987) - will open on Tuesday in Lisbon Champalimaud Center of the Unknown, which will put this country without first class scientific tradition, on the cutting edge of cancer research, with 300 scientists and hundreds of physicians. With an investment of 120 million euros, the particularity of the new complex that will combine research and medical care. "It's a rather unique case. Patients may see researchers working in laboratories. And again, the researchers will see patients admitted to hospital," says the center's director, Raghu Kalluri, Professor of Medicine Harvard University.
 

The building has been designed and built with this objective in a spectacular location on the river Tajo. From the reception you can see through a glass, a huge part of the laboratory. The designer of the center is the architect Charles Correa, an Indian from Goa, a former Portuguese colony, author of the largest neuroscience research center in the world, at MIT. "The reception is what I call the window of hope, because patients see their arrival not only medical but also to researchers," said the world-renowned urban planner.
 
 The middle star Champalimaud program will be devoted to research, prevention and treatment of metastases, in collaboration with three major U.S. universities, Harvard Medical School, Weill Cornell Medical College and Princeton. "The idea is to transfer the knowledge of America to Lisbon in the coming years. We will work with fifteen sites around the world. We have received many requests from the University of Chicago, Texas, centers of Singapore, Germany, France, United Kingdom ... "
 
 The center's director is convinced that it is a great opportunity for Portugal. "Look at India. 20 years ago, if I had said that this country would be where you are today, I would not have believed it. Today is a leader in various sectors. I think this will happen in Lisbon center. The connection with universities around the planet will bring many experts to establish laboratories that will serve as the United States and other countries. " Kalluri, of Indian origin, will divide his time between Boston and Lisbon.
 
 The center will have several programs, cancer, neuroscience, education, training, and begin with the different types of diseases that affect women, to gradually include other specialties. An international scientific committee will advise on the recruitment of physicians and researchers and provide guidelines for creating "the best atmosphere." Leonor Beleza, president of the Champalimaud Foundation and former Health Minister, visited universities, foundations and laboratories and spoke with experts on your project. I had a good bond, EUR 500 million for biomedical research won António Champalimaud, the richest man in Portugal, died in 2004. The center that opens today is the result of much travel.
 
In one of them met Beleza Catalan researcher Joan Massagué, the prestigious Sloan-Kettering Medical Center, New York. "He convinced me that every day makes less sense to distinguish between basic research and clinical research. The idea of bringing together people with diverse experiences and knowledge, including those facing the disease, is critical to achieving results." The hospital will start in April, with the goal of welcoming approximately 1,000 patients per year.
 
 A center of such a high level will be accessible to all people, especially the least resources? "We do not want a center for the more humble prohibitive. We would not have access to only the rich or those who come from abroad," Beleza says, it is in talks "on track" with the Portuguese National Health System and mutual private, in order to care for patients of all walks of life. He emphasizes that the center Champalimaud is not like any private school in Portugal. "We are a center for philanthropy. All proceeds are reinvested in science, not distributed to shareholders."
 
 50% of the 60,000 square feet it occupies the center will use public-gardens, outdoor amphitheater, with no barriers. "It's a space that will serve the people, where citizens have access to the river in an area where none had."
 

advertisement

 

Advertisement

Beach Deals (180x150)